ГоловнаArchive of numbers2020Volume 28, issue 4 (105)Psychotic disorders in COVID-19: mechanisms of development, clinical and treatment features
Title of the article Psychotic disorders in COVID-19: mechanisms of development, clinical and treatment features
Authors Yuryeva Liudmyla
Shornikov Andrii
Year 2020 Issue Volume 28, issue 4 (105) Pages 13-17
Type of article Scientific article Index UDK 616.89-02-022:578.834-616-092.11-616.89-02-07 Index BBK -

The purpose of this review was to study the mechanisms of development, clinical features and treatment of psychotic disorders during the disease caused by the SARS-CoV-2 virus. In the first part of the review, especial attention was paid to the available literature data on the mechanisms of development of mental disorders in COVID-19. Among the main pathogenetic mechanisms of the onset of psychotic disorders in coronavirus infections, there are direct effects of a viral infection (including a brain infection), cerebrovascular diseases, hypoxia, an immunological response, the consequences of medical interventions, social isolation, the psychological impact of a severe and potentially fatal illness, fears of infecting another’s and stigmatization. The second part of the publication is devoted to a review of clinical studies and syndromokinesis in infectious and coronavirus psychoses. Particular attention is paid to delirious syndrome, including pharmacogenic delirium and antibiotic-associated encephalopathy. The article describes the features of therapy for psychotic disorders in COVID-19, taking into account drug‑drug interactions and the effect on the cardiovascular and respiratory systems. The analyzed literature allows us to make a reasonable conclusion that the management of coronavirus psychoses should be aimed at treating the underlying disease while eliminating psychotic symptoms with antipsychotics while ensuring maximum safety of psychopharmacotherapy.
Key words COVID-19, pathogenesis, infectious psychosis, delirium, treatment
Access to full text version of the article pdf download
1. Rogers, J. P., Chesney, E., Oliver, D., Pollak, T. A., McGuire, P., Fusar-Poli, P., Zandi, M. S., Lewis, G., & David, A. S. (2020). Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: A systematic review and meta-analysis with comparison to the COVID-19 pandemic. The Lancet. Psychiatry, 7(7), 611. https://doi.org/10.1016/S2215-0366(20)30203-0
2. Taquet, M., Luciano, S., Geddes, J. R., & Harrison, P. J. (2020). Bidirectional associations between COVID-19 and psychiatric disorder: Retrospective cohort studies of 62 354 COVID-19 cases in the USA. The Lancet Psychiatry. https://doi.org/10.1016/S2215-0366(20)30462-4
3. Ji, W., Huh, K., Kang, M., Hong, J., Bae, G. H., Lee, R., Na, Y., Choi, H., Gong, S. Y., Choi, Y.-H., Ko, K.-P., Im, J.-S., & Jung, J. (2020). Effect of Underlying Comorbidities on the Infection and Severity of COVID-19 in Korea: A Nationwide Case-Control Study. Journal of Korean Medical Science, 35(25). https://doi.org/10.3346/jkms.2020.35.e237
4. Yang, H., Chen, W., Hu, Y., Chen, Y., Zeng, Y., Sun, Y., Ying, Z., He, J., Qu, Y., Lu, D., Fang, F., Valdimarsdóttir, U. A., & Song, H. (2020). Pre-pandemic psychiatric disorders and risk of COVID-19: A UK Biobank cohort analysis. The Lancet Healthy Longevity, 1(2), e69–e79. https://doi.org/10.1016/S2666-7568(20)30013-1
5. Severance, E. G., Dickerson, F. B., Viscidi, R. P., Bossis, I., Stallings, C. R., Origoni, A. E., Sullens, A., & Yolken, R. H. (2011). Coronavirus Immunoreactivity in Individuals With a Recent Onset of Psychotic Symptoms. Schizophrenia Bulletin, 37(1), 101–107. https://doi.org/10.1093/schbul/sbp052
6. Chacko, M., Job, A., Caston, F., George, P., Yacoub, A., & Cáceda, R. (2020). COVID-19-Induced Psychosis and Suicidal Behavior: Case Report. SN Comprehensive Clinical Medicine. https://doi.org/10.1007/s42399-020-00530-7
7. Brown, E., Gray, R., Lo Monaco, S., O’Donoghue, B., Nelson, B., Thompson, A., Francey, S., & McGorry, P. (2020). The potential impact of COVID-19 on psychosis: A rapid review of contemporary epidemic and pandemic research. Schizophrenia Research, 222, 79–87. https://doi.org/10.1016/j.schres.2020.05.005
8. Compton, M. T., & Shim, R. S. (2015). The Social Determinants of Mental Health. FOCUS, 13(4), 419–425. https://doi.org/10.1176/appi.focus.20150017
9. Anglin, D. M., Galea, S., & Bachman, P. (2020). Going Upstream to Advance Psychosis Prevention and Improve Public Health. JAMA Psychiatry, 77(7), 665–666. https://doi.org/10.1001/jamapsychiatry.2020.0142
10. Ferrando, S. J., Klepacz, L., Lynch, S., Tavakkoli, M., Dornbush, R., Baharani, R., Smolin, Y., & Bartell, A. (2020). COVID-19 Psychosis: A Potential New Neuropsychiatric Condition Triggered by Novel Coronavirus Infection and the Inflammatory Response? Psychosomatics, 61(5), 551–555. https://doi.org/10.1016/j.psym.2020.05.012
11. Troyer, E. A., Kohn, J. N., & Hong, S. (2020). Are we facing a crashing wave of neuropsychiatric sequelae of COVID-19? Neuropsychiatric symptoms and potential immunologic mechanisms. Brain, Behavior, and Immunity, 87, 34–39. https://doi.org/10.1016/j.bbi.2020.04.027
12. Mirza, J., Ganguly, A., Ostrovskaya, A., Tusher, A., & Viswanathan, R. (2020). Command Suicidal Hallucination as Initial Presentation of Coronavirus Disease 2019 (COVID-19): A Case Report. Psychosomatics, 61(5), 561–564. https://doi.org/10.1016/j.psym.2020.05.022
13. Wu, Y., Xu, X., Chen, Z., Duan, J., Hashimoto, K., Yang, L., Liu, C., & Yang, C. (2020). Nervous system involvement after infection with COVID-19 and other coronaviruses. Brain, Behavior, and Immunity, 87, 18–22. https://doi.org/10.1016/j.bbi.2020.03.031
14. Cheng, S. K.-W., Tsang, J. S.-K., Ku, K.-H., Wong, C.-W., & Ng, Y.-K. (2004). Psychiatric complications in patients with severe acute respiratory syndrome (SARS) during the acute treatment phase: A series of 10 cases. The British Journal of Psychiatry, 184(4), 359–360. https://doi.org/10.1192/bjp.184.4.359
15. Smith, C. M., Komisar, J. R., Mourad, A., & Kincaid, B. R. (2020). COVID-19-associated brief psychotic disorder. BMJ Case Reports, 13(8), e236940. https://doi.org/10.1136/bcr-2020-236940
16. Yureva, L. N., & Shusterman, T. Y. (2020). Pandemyia COVID-19: Rysky dlia psykholohycheskoho blahopoluchyia y psykhycheskoho zdorovia. Ukrainskyi visnyk psykhonevrolohii, 28(2), 5–10. https://doi.org/10.36927/2079-0325-V28-is2-2020-1
17. Abaturov, O. Ye., Kramarov, S. O., & Yurieva, L. M. (Eds.). (2020). Likuvannia ta profilaktyka COVID-19. Okhorona psykhichnoho zdorovia v umovakh pandemii. Lviv: Vydavets Marchenko T.V., 2020. 252 p.
18. Beach, S. R., Praschan, N. C., Hogan, C., Dotson, S., Merideth, F., Kontos, N., Fricchione, G. L., & Smith, F. A. (2020). Delirium in COVID-19: A case series and exploration of potential mechanisms for central nervous system involvement. General Hospital Psychiatry, 65, 47–53. https://doi.org/10.1016/j.genhosppsych.2020.05.008
19. Bhattacharyya, S., Darby, R. R., Raibagkar, P., Gonzalez Castro, L. N., & Berkowitz, A. L. (2016). Antibiotic-associated encephalopathy. Neurology, 86(10), 963–971. https://doi.org/10.1212/WNL.0000000000002455
20. Levenson, J. L. (2018). The American Psychiatric Association Publishing Textbook of Psychosomatic Medicine and Consultation-Liaison Psychiatry (Third Edition). American Psychiatric Association Publishing. https://doi.org/10.1176/appi.books.9781615371990.
21. Asselman, V., Thienemann, F., Pepper, D. J., Boulle, A., Wilkinson, R. J., Meintjes, G., & Marais, S. (2010). Central nervous system disorders after starting antiretroviral therapy in South Africa: AIDS, 24(18), 2871–2876. https://doi.org/10.1097/QAD.0b013e328340fe76.
22. Gatch, M. B., Kozlenkov, A., Huang, R.-Q., Yang, W., Nguyen, J. D., González-Maeso, J., Rice, K. C., France, C. P., Dillon, G. H., Forster, M. J., & Schetz, J. A. (2013). The HIV Antiretroviral Drug Efavirenz has LSD-Like Properties. Neuropsychopharmacology, 38(12), 2373–2384. https://doi.org/10.1038/npp.2013.135.
23. Huremović, D. (Ed.). (2019). Psychiatry of Pandemics: A Mental Health Response to Infection Outbreak. Springer International Publishing. https://doi.org/10.1007/978-3-030-15346-5.
24. Huarcaya-Victoria, J., Meneses-Saco, A., & Luna-Cuadros, M. A. (2020). Psychotic symptoms in COVID-19 infection: A case series from Lima, Peru. Psychiatry Research, 293, 113378. https://doi.org/10.1016/j.psychres.2020.113378.
25. Valdés-Florido, M. J., López-Díaz, Á., Palermo-Zeballos, F. J., Martínez-Molina, I., Martín-Gil, V. E., Crespo-Facorro, B., & Ruiz-Veguilla, M. (2020). Reactive psychoses in the context of the COVID-19 pandemic: Clinical perspectives from a case series. Revista De Psiquiatria Y Salud Mental, 13(2), 90–94. https://doi.org/10.1016/j.rpsm.2020.04.009.
26. Duan, L., Shao, X., Wang, Y., Huang, Y., Miao, J., Yang, X., & Zhu, G. (2020). An investigation of mental health status of children and adolescents in china during the outbreak of COVID-19. Journal of Affective Disorders, 275, 112–118. https://doi.org/10.1016/j.jad.2020.06.029.
27. Szcześniak, D., Gładka, A., Misiak, B., Cyran, A., & Rymaszewska, J. (2021). The SARS-CoV-2 and mental health: From biological mechanisms to social consequences. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 104, 110046. https://doi.org/10.1016/j.pnpbp.2020.110046
28. Mawhinney, J. A., Wilcock, C., Haboubi, H., & Roshanzamir, S. (2020). Neurotropism of SARS-CoV-2: COVID-19 presenting with an acute manic episode. BMJ Case Reports CP, 13(6), e236123. https://doi.org/10.1136/bcr-2020-236123
29. Yuryeva, L.M. (Ed.). (2019). Orhanichni psykhichni rozlady: Diahnostyka, reabilitatsiia ta profilaktyka. Nova ideolohiia , 2019. 124 p.
30. Li, P., Wang, Y., Peppelenbosch, M. P., Ma, Z., & Pan, Q. (2020). Systematically comparing COVID-19 with 2009 influenza pandemic for hospitalized patients. International Journal of Infectious Diseases. https://doi.org/10.1016/j.ijid.2020.11.127
31. González-Rodríguez, A., & Labad, J. (2020). Mental health in times of COVID: Thoughts after the state of alarm. Medicina Clinica (English Ed.), 155(9), 392–394. https://doi.org/10.1016/j.medcle.2020.07.007
32. Voloshyn, P. V., Maruta, N. O., Linskyi, I. V., Zilberblat, H. M., Kutikov, O. Ye., Minko, O. I., Mishyiev, V. D., Pidkorytov, V. S., & Shestopalova, L. F. (2020). Rekomendatsii Asotsiatsii nevrolohiv, psykhiatriv i narkolohiv Ukrainy shchodo nadannia psykhiatrychnoi dopomohy v period epidemii COVID-19. https://inpn.org.ua/news/34